Prognostic Effect Of Comorbidities Among Patients With Chronic Myeloid Leukemia In Chronic Phase Treated With Second Generation Tyrosine Kinase Inhibitors A Five Year Retrospective Study | Philippine College of Hematology and Transfusion Medicine

PHILIPPINE COLLEGE OF HEMATOLOGY AND TRANSFUSION MEDICINE

Upcoming Events:
PCHTM 7th Annual Convention

Upcoming Events: PCHTM 7th Annual Convention

Prognostic Effect of Comorbidities Among Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Second Generation Tyrosine Kinase Inhibitors: A Five-Year Retrospective Study Venessa S. Ediza MD¹ , Anne Kristine H. Quero-Taggaoa,MD² Contact: vanediza08@gmail.com

Graft Versus Host Disease, A Rare Side Effect Of Covid 19 Mrna Vaccines In Post Allogeneic Hematopoietic Stem Cell Transplant Patients : A Case Series
Mary Anne Lorraine Kua, MD & Internal Medicine-Hematology Fellow & Francisco Vicente Lopez, M

Clinical Profile And Management Outcomes Of Adult Filipino Patients With Hemophagocytic Lymphohistiocytosis In A Tertiary Hospital
Eunice P. Empeño, MD